AQR Capital Management
ARIA

AQR Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

AQR Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-191,513
Closed -$2.38M – 2321
2016
Q4 		$2.38M Buy
191,513
+77,857
+69% +$938K ﹤0.01% 1325
2016
Q3 		$1.56M Buy
+113,656
New +$1.14M ﹤0.01% 1531
2016
Q1 		– Sell
-41,130
Closed -$257K – 2350
2015
Q4 		$257K Sell
41,130
-82,800
-67% -$543K ﹤0.01% 2073
2015
Q3 		$724K Buy
123,930
+36,743
+42% +$283K ﹤0.01% 1589
2015
Q2 		$721K Sell
87,187
-80,913
-48% -$716K ﹤0.01% 1647
2015
Q1 		$1.39M Sell
168,100
-554,196
-77% -$4.1M ﹤0.01% 1276
2014
Q4 		$4.96M Sell
722,296
-721,418
-50% -$4.51M 0.01% 911
2014
Q3 		$7.8M Sell
1,443,714
-2,439,116
-63% -$14.2M 0.02% 672
2014
Q2 		$24.7M Buy
3,882,830
+2,959,312
+320% +$20.4M 0.07% 361
2014
Q1 		$7.44M Sell
923,518
-569,600
-38% -$4.44M 0.02% 696
2013
Q4 		$10.2M Buy
1,493,118
+1,413,174
+1,768% +$7.63M 0.03% 586
2013
Q3 		$1.47M Buy
79,944
+31,926
+66% +$620K 0.01% 1447
2013
Q2 		$840K Buy
+48,018
New +$851K ﹤0.01% 1659

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

AQR Capital Management's ARIA Position: Q1 2017 in Review

AQR Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 191,513 shares — an estimated $2.38M sold.

AQR Capital Management first reported a position in ARIA in Q2 2013 and held it in 13 quarters. The position peaked at $24.7M in Q2 2014. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • AQR Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • AQR Capital Management sold 191,513 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.38M.
  • AQR Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 13 quarters.
  • AQR Capital Management's Ariad Pharmaceuticals Inc position peaked at $24.7M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on AQR Capital Management's 13F filing for Q1 2017, filed 15 May 2017.